Enes Erul

977 total citations · 2 hit papers
34 papers, 610 citations indexed

About

Enes Erul is a scholar working on Oncology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Enes Erul has authored 34 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Infectious Diseases and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Enes Erul's work include Cancer Immunotherapy and Biomarkers (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 Clinical Research Studies (5 papers). Enes Erul is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 Clinical Research Studies (5 papers). Enes Erul collaborates with scholars based in Türkiye, United States and Italy. Enes Erul's co-authors include Deniz Can Güven, Taha Koray Şahin, Sercan Aksoy, Saadettin Kılıçkap, Alessandro Rizzo, Şuayib Yalçın, Thilo Gambichler, Angela Dalia Ricci, Raffaele De Luca and Baran Akagündüz and has published in prestigious journals such as International Journal of Cancer, Annals of the Rheumatic Diseases and The Oncologist.

In The Last Decade

Enes Erul

27 papers receiving 607 citations

Hit Papers

The association between albumin levels and survival in pa... 2022 2026 2023 2024 2022 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enes Erul Türkiye 11 304 155 119 94 87 34 610
Gaurav Prakash India 15 206 0.7× 115 0.7× 144 1.2× 70 0.7× 43 0.5× 173 818
Yahua Zhong China 15 296 1.0× 110 0.7× 191 1.6× 53 0.6× 122 1.4× 56 622
Hakan Harputluoğlu Türkiye 14 364 1.2× 168 1.1× 63 0.5× 66 0.7× 47 0.5× 49 728
Mengyang Di United States 15 303 1.0× 127 0.8× 129 1.1× 204 2.2× 78 0.9× 54 770
Kelsey L. Corrigan United States 12 296 1.0× 97 0.6× 93 0.8× 98 1.0× 46 0.5× 52 585
Pierre-Étienne Heudel France 17 558 1.8× 319 2.1× 132 1.1× 129 1.4× 133 1.5× 95 990
Alexandre A. Jácome Brazil 16 315 1.0× 178 1.1× 88 0.7× 153 1.6× 56 0.6× 45 574
Hyery Kim South Korea 16 152 0.5× 74 0.5× 110 0.9× 89 0.9× 34 0.4× 100 665
Harold C. Sullivan United States 16 198 0.7× 131 0.8× 136 1.1× 195 2.1× 28 0.3× 43 828
Jurjen Versluis Netherlands 13 305 1.0× 132 0.9× 120 1.0× 48 0.5× 34 0.4× 43 747

Countries citing papers authored by Enes Erul

Since Specialization
Citations

This map shows the geographic impact of Enes Erul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enes Erul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enes Erul more than expected).

Fields of papers citing papers by Enes Erul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enes Erul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enes Erul. The network helps show where Enes Erul may publish in the future.

Co-authorship network of co-authors of Enes Erul

This figure shows the co-authorship network connecting the top 25 collaborators of Enes Erul. A scholar is included among the top collaborators of Enes Erul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enes Erul. Enes Erul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caturano, Alfredo, Enes Erul, Vincenzo Russo, et al.. (2025). Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad. European Journal of Clinical Investigation. 56(1). e70132–e70132.
3.
Caturano, Alfredo & Enes Erul. (2025). The impact of incidental hepatocellular carcinoma in liver transplantation: A growing concern. Clinics and Research in Hepatology and Gastroenterology. 49(3). 102550–102550.
5.
Caturano, Alfredo, Enes Erul, Vincenzo Russo, et al.. (2025). Insulin resistance and cancer: molecular links and clinical perspectives. Molecular and Cellular Biochemistry. 480(7). 3995–4014. 2 indexed citations
6.
Erul, Enes, et al.. (2025). Perceptions, Attitudes, and Concerns on Artificial Intelligence Applications in Patients with Cancer. Cancer Control. 32. 2935761293–2935761293. 3 indexed citations
7.
Güven, Deniz Can, et al.. (2024). The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review. The Oncologist. 29(5). e580–e600. 19 indexed citations
9.
Erul, Enes, et al.. (2024). Primary Prostatic Stromal Sarcoma: A Case Report and Review of the Literature. Medicina. 60(12). 1918–1918. 1 indexed citations
10.
Güven, Deniz Can, Hasan Çağrı Yıldırım, Enes Erul, et al.. (2023). Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment. Expert Review of Anticancer Therapy. 23(10). 1049–1059. 5 indexed citations
11.
Erul, Enes, Deniz Can Güven, Mehmet Ruhi Onur, Gözde Yazıcı, & Sercan Aksoy. (2023). Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives. European Archives of Oto-Rhino-Laryngology. 280(8). 3541–3556. 20 indexed citations
12.
Sönmezer, Meli̇ha Çağla, et al.. (2022). Knowledge, Attitudes, and Perception towards COVID-19 Vaccination among the Adult Population: A Cross-Sectional Study in Turkey. Vaccines. 10(2). 278–278. 26 indexed citations
13.
Güven, Deniz Can, Taha Koray Şahin, Enes Erul, et al.. (2022). The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy. Journal of Clinical Medicine. 11(15). 4523–4523. 22 indexed citations
14.
Güven, Deniz Can, et al.. (2022). The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials. Critical Reviews in Oncology/Hematology. 174. 103700–103700. 11 indexed citations
15.
Güven, Deniz Can, Emre Yekedüz, Enes Erul, et al.. (2022). The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study. Journal of Cancer Research and Clinical Oncology. 149(7). 3599–3606. 5 indexed citations
17.
Güven, Deniz Can, Taha Koray Şahin, Enes Erul, et al.. (2022). The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Frontiers in Molecular Biosciences. 9. 1039121–1039121. 138 indexed citations breakdown →
18.
Güven, Deniz Can, Enes Erul, Hasan Çağrı Yıldırım, et al.. (2022). The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 280(5). 2471–2478. 21 indexed citations
19.
Erul, Enes, Deniz Can Güven, Taha Koray Şahin, & İbrahim Güllü. (2021). Thyroid gland metastasis mimicking thyroid carcinoma in a lung cancer patient and dramatic response to crizotinib: A case report. Tuberkuloz ve Toraks. 69(1). 98–101.
20.
Şimşek, Cem, Enes Erul, & Hatice Balaban. (2021). Role of gastrointestinal system on transmission and pathogenesis of SARS-CoV-2. World Journal of Clinical Cases. 9(20). 5427–5434. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026